Merone, Italy

Andrea Vanossi

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Industriale Chimica S.r.l.. Active years: 2016.


% Patents Active = 100.0


 

Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Andrea Vanossi: Innovator in Pharmaceutical Chemistry

Introduction

Andrea Vanossi is a prominent inventor based in Merone, Italy. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of compounds with pharmacological activity. With a total of two patents to her name, Vanossi's work is recognized for its impact on the development of important medicinal compounds.

Latest Patents

Vanossi's latest patents include a process for preparing 11-methylene-18-methyl-estr-4-en-3, 17-dione. This compound serves as an intermediate in the synthesis of progestin compounds such as Desogestrel and Etonogestrel. Additionally, she has developed a process for the preparation of drospirenone, a synthetic steroid known for its progestogenic, antimineralocorticoid, and antiandrogenic activities. This compound is essential for creating pharmaceutical compositions with contraceptive action.

Career Highlights

Andrea Vanossi works at Industriale Chimica S.r.l., where she applies her expertise in chemical synthesis to advance pharmaceutical research. Her innovative approaches have led to the development of processes that enhance the efficiency and effectiveness of drug production.

Collaborations

Vanossi collaborates with notable colleagues, including Roberto Lenna and Edoardo Mariani. These partnerships foster a dynamic environment for research and innovation in the pharmaceutical sector.

Conclusion

Andrea Vanossi's contributions to pharmaceutical chemistry exemplify the importance of innovation in drug development. Her patents reflect a commitment to advancing medical science and improving healthcare outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…